DZS Clinical Services and Software Revenue and Competitors
Estimated Revenue & Valuation
- DZS Clinical Services and Software's estimated annual revenue is currently $8M per year.
- DZS Clinical Services and Software's estimated revenue per employee is $201,000
Employee Data
- DZS Clinical Services and Software has 40 Employees.
DZS Clinical Services and Software's People
Name | Title | Email/Phone |
---|---|---|
1 | Director, Clinical Operations | Reveal Email/Phone |
2 | Project Coordinator | Reveal Email/Phone |
DZS Clinical Services and Software Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $71M | 300 | -3% | N/A | N/A |
#2 | $668.1M | 3222 | 3% | $20M | N/A |
#3 | $5.3M | 46 | N/A | N/A | N/A |
#4 | $5.1M | 46 | -13% | $950K | N/A |
#5 | $1.7M | 23 | -4% | $30M | N/A |
#6 | $0.7M | 9 | N/A | N/A | N/A |
#7 | $0.7M | 9 | N/A | N/A | N/A |
#8 | $0.6M | 8 | N/A | N/A | N/A |
#9 | $2.5M | 25 | N/A | N/A | N/A |
#10 | $14.2M | 98 | N/A | N/A | N/A |
#11 | $5060M | 7612 | -20% | $6.9M | $22.5B |
#12 | $53.7M | 302 | 7% | $8M | N/A |
#13 | $3.8M | 33 | N/A | N/A | N/A |
#14 | $4.2M | 21 | N/A | N/A | N/A |
#15 | $7.6M | 58 | 32% | N/A | N/A |
#16 | $25.7M | 161 | N/A | N/A | N/A |
#17 | $1167M | 5806 | N/A | N/A | N/A |
#18 | $16.5M | 82 | N/A | N/A | N/A |
#19 | $12.7M | 91 | -9% | $17.2M | N/A |
#20 | N/A | 39 | N/A | N/A | N/A |
What Is DZS Clinical Services and Software?
N/A
Total Funding
40
Number of Employees
$8M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
DZS Clinical Services and Software News
2022-04-20 - Clinical Trial Management Software Market- increasing ...
Oracle, MedNet Solutions, Medidata Solutions, Bioclinica, IBM, PAREXEL, DSG, Veeva Systems, Forte Research Systems, ERT, Bio-Optronics, DZS Software Solutions,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6.7M | 40 | -7% | N/A |
#2 | $5.8M | 50 | 9% | N/A |
#3 | $12.9M | 53 | 6% | N/A |
#4 | N/A | 54 | 4% | N/A |
#5 | $16.7M | 74 | 6% | N/A |